Should patients with drug-resistant HIV-1 continue to receive antiretroviral therapy?
- PMID: 11172196
- DOI: 10.1056/NEJM200102153440710
Should patients with drug-resistant HIV-1 continue to receive antiretroviral therapy?
Comment on
-
Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.N Engl J Med. 2001 Feb 15;344(7):472-80. doi: 10.1056/NEJM200102153440702. N Engl J Med. 2001. PMID: 11172188 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical